Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine-induced hepatic steatosis via both receptor-dependent and receptor-independent pathways.
FASEB J. 2024 Feb 29;38(4):e23464. doi: 10.1096/fj.202301748R.
FASEB J. 2024.
PMID: 38358343
Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.
Ding C, Tang Y, Zhu W, Huang P, Lian P, Ran J, Huang X.
Ding C, et al.
Acta Diabetol. 2022 Apr;59(4):519-533. doi: 10.1007/s00592-021-01830-7. Epub 2022 Jan 6.
Acta Diabetol. 2022.
PMID: 34988690
Item in Clipboard
Cite
Cite